Treatment of colorectal, stomach, and lung cancer in dialysis patients in Osaka Prefecture

DOI Web Site Web Site 15 References
  • Kida Nanami
    Cancer Control Center, Osaka International Cancer Institute Department of Clinical Engineering, Jikei University of Health Care Sciences Department of Health Economics and Management, Osaka University Graduate School of Medicine
  • Morishima Toshitaka
    Cancer Control Center, Osaka International Cancer Institute
  • Tsubakihara Yoshiharu
    Department of Safety Management in Health Care Sciences, Graduate School of Medical Safety Management, Jikei University of Health Care Sciences

Bibliographic Information

Other Title
  • 大阪府における透析患者の大腸，胃，肺がんの治療実態
  • オオサカフ ニ オケル トウセキ カンジャ ノ ダイチョウ,イ,ハイ ガン ノ チリョウ ジッタイ

Search this article

Abstract

<p>Cancer is the third most common cause of death among dialysis patients in Japan. Nevertheless, there are no guidelines for the treatment of cancer in dialysis patients. This study aimed to examine the treatment of cancer in dialysis patients and non‒dialysis patients according to cancer stage in real‒world settings. In this multicenter retrospective cohort study, cancer registry data and administrative data were used to identify dialysis patients (n＝687) and non‒dialysis patients (n＝47900) aged 18‒79 years who were newly diagnosed with colorectal, stomach, or lung cancer between 2010 and 2015 at 36 hospitals in Osaka Prefecture, Japan. The records of these datasets were linked to obtain patient‒level information about dialysis treatment, cancer diagnoses, and cancer‒specific treatments. Dialysis patients were significantly more likely to undergo endoscopic resection and less likely to undergo surgical resection for early‒stage colorectal and stomach cancer than non‒dialysis patients. Dialysis patients were significantly more likely to receive radiotherapy for early‒stage lung cancer. Dialysis patients were significantly less likely to undergo combination treatment involving surgical resection and chemotherapy for colorectal, stomach, or lung cancer of any stage. Dialysis patients were significantly less likely to receive chemotherapy alone for distant recurrent stomach or lung cancer. Dialysis patients were significantly less likely to receive any treatment for lung cancer, regardless of its stage. In conclusion, dialysis patients were less likely to receive aggressive treatment for cancer than non‒dialysis patients. This study supports the development of evidence‒based practice guidelines for the treatment, particularly using chemotherapy, of cancer in dialysis patients.</p>

Journal

References(15)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top